102 related articles for article (PubMed ID: 14712088)
1. B-raf and insulin synergistically prevent apoptosis and induce cell cycle progression in hematopoietic cells.
Shelton JG; Chang F; Lee JT; Franklin RA; Steelman LS; McCubrey JA
Cell Cycle; 2004 Feb; 3(2):189-96. PubMed ID: 14712088
[TBL] [Abstract][Full Text] [Related]
2. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.
Hoyle PE; Moye PW; Steelman LS; Blalock WL; Franklin RA; Pearce M; Cherwinski H; Bosch E; McMahon M; McCubrey JA
Leukemia; 2000 Apr; 14(4):642-56. PubMed ID: 10764150
[TBL] [Abstract][Full Text] [Related]
3. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells.
Weinstein-Oppenheimer C; Steelman LS; Algate PA; Blalock WL; Burrows C; Hoyle PE; Lee JT; Moye PW; Shelton JG; Franklin R; McCubrey JA
Leukemia; 2000 Nov; 14(11):1921-38. PubMed ID: 11069028
[TBL] [Abstract][Full Text] [Related]
4. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.
Shelton JG; Blalock WL; White ER; Steelman LS; McCubrey JA
Cell Cycle; 2004 Apr; 3(4):503-12. PubMed ID: 15004527
[TBL] [Abstract][Full Text] [Related]
5. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
[TBL] [Abstract][Full Text] [Related]
6. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells.
McCubrey JA; Steelman LS; Hoyle PE; Blalock WL; Weinstein-Oppenheimer C; Franklin RA; Cherwinski H; Bosch E; McMahon M
Leukemia; 1998 Dec; 12(12):1903-29. PubMed ID: 9844921
[TBL] [Abstract][Full Text] [Related]
7. P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells.
Chang F; McCubrey JA
Oncogene; 2001 Jul; 20(32):4354-64. PubMed ID: 11466616
[TBL] [Abstract][Full Text] [Related]
8. Raf-induced cell cycle progression in human TF-1 hematopoietic cells.
Chang F; Steelman LS; McCubrey JA
Cell Cycle; 2002; 1(3):220-6. PubMed ID: 12429936
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
[TBL] [Abstract][Full Text] [Related]
10. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; White ER; McCubrey JA
Cell Cycle; 2004 Mar; 3(3):372-9. PubMed ID: 14726697
[TBL] [Abstract][Full Text] [Related]
11. Development of a conditional in vivo model to evaluate the efficacy of small molecule inhibitors for the treatment of Raf-transformed hematopoietic cells.
Konopleva M; Shi Y; Steelman LS; Shelton JG; Munsell M; Marini F; McQueen T; Contractor R; McCubrey JA; Andreeff M
Cancer Res; 2005 Nov; 65(21):9962-70. PubMed ID: 16267021
[TBL] [Abstract][Full Text] [Related]
12. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells.
Moye PW; Blalock WL; Hoyle PE; Chang F; Franklin RA; Weinstein-Oppenheimer C; Pearce M; Steelman L; McMahon M; McCubrey JA
Leukemia; 2000 Jun; 14(6):1060-79. PubMed ID: 10865973
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells.
Blalock WL; Moye PW; Chang F; Pearce M; Steelman LS; McMahon M; McCubrey JA
Leukemia; 2000 Jun; 14(6):1080-96. PubMed ID: 10865974
[TBL] [Abstract][Full Text] [Related]
14. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
[TBL] [Abstract][Full Text] [Related]
15. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events.
Hambleton J; McMahon M; DeFranco AL
J Exp Med; 1995 Jul; 182(1):147-54. PubMed ID: 7790814
[TBL] [Abstract][Full Text] [Related]
16. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
[TBL] [Abstract][Full Text] [Related]
17. The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line.
Weinstein-Oppenheimer CR; Burrows C; Steelman LS; McCubrey JA
Cancer Biol Ther; 2002; 1(3):256-62. PubMed ID: 12432273
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA
Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299
[TBL] [Abstract][Full Text] [Related]
19. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.
McCubrey JA; Lee JT; Steelman LS; Blalock WL; Moye PW; Chang F; Pearce M; Shelton JG; White MK; Franklin RA; Pohnert SC
Cancer Detect Prev; 2001; 25(4):375-93. PubMed ID: 11531015
[TBL] [Abstract][Full Text] [Related]
20. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
